MIRA INFORM REPORT

 

 

 

Report Date :

24.07.2008

 

IDENTIFICATION DETAILS

 

Name :

NEISS LABS PRIVATE LIMITED

 

 

Registered Office :

D-64/52 - K Madhopur Sigra, Varanasi – 221 010, Uttar Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2007

 

 

Date of Incorporation :

08.01.2001

 

 

Com. Reg. No.:

20-25821

 

 

CIN No.:

[Company Identification No.]

U25233UP2001PTC025821

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

ALDN00198C

 

 

PAN No.:

[Permanent Account No.]

AABCN5481C

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Pharmaceutical Formulations and Generic Medicine.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

Delayed

 

 

Litigation :

Clear

 

 

Comments :

Mr. Mohit Jain, Director remained non-cooperative saying that he is extremely busy to attend MIRA / TRUST SEAL business.

 

The company has moderate track records of performance and financial status.

 

It’s payments are slow and delayed.

 

The company can be considered for small to mediocre business dealings at usual trade terms and conditions only.

 

 

INFORMATION DECLINED BY

 

Name :

Mr. Mohit Jain

Designation :

Director

Date :

10.07.2008

 

 

LOCATIONS

 

Registered Office :

D-64/52 - K Madhopur Sigra, Varanasi – 221 010, Uttar Pradesh, India

E-Mail :

tsspl11@yahoo.com

kkumar__srivastava@yahoo.co.in

neiss@rediffmail.com

 

 

Corporate Office :

330/2642 Motilal Nagar – 2, Link Road, Goregaon (West), Mumbai – 400 090, Maharashtra, India

Tel. No.:

91-22-28745373 / 65146601 / 02

Mobile

91-9321026889

Fax No.:

91-22-28745067

E-Mail :

exports@neisslabs.com

neisslabs@gmail.com

 

 

Brach Office :

SCO – 27, Sector – 54, Phase – 2, Mohali – 54, Chandigad, India

Tel. No.:

91-172-5097800

 

 

DIRECTORS

 

Name :

Mr. Mohit Jain

Designation :

Director

Address :

D-64/52-K Madhopur Sigra, Varanasi – 221 010, Uttar Pradesh, India

Date of Birth/Age :

03.01.1978

Date of Appointment :

08.01.2001

 

 

Name :

Mr. Manish Jain

Designation :

Director

Address :

D-64/52-K Madhopur Sigra, Varanasi – 221 010, Uttar Pradesh, India

Date of Birth/Age :

18.04.1976

Date of Appointment :

08.01.2001

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

(As on 30.09.2005)

 

Names of Shareholders

No. of Shares

Mohit Jain

5000

Manish Jain

5000

Total

10000

 

Equity shares Breakup (percentage of total equity)

 

(As on 30.09.2007)

 

Category

Percentage

Directors or relative of directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Pharmaceutical Formulations and Generic Medicine.

 

 

Products :

·         Tablets and Capsules Section

·         Liquid Medicines

·         Injectables

·         Eye and Ear Drops

·         Ointment Section

·         Ayurvedic Section

·         Anti Cancer Section

·         Speciality Medicines

 

 

GENERAL INFORMATION

 

Bankers :

v      Punjab National Bank

Varanasi

 

v      HSBC Bank

 

 

 

Banking Relations :

Unknown

 

 

Auditors :

 

Name :

S. Ahuja and Associates

Chartered Accountants

Address :

2nd Floor, Urvashi Complex, Gandhi Nagar Sigra, Varanasi – 221 010, Uttar Pradesh, India

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

40000

Equity Shares

Rs. 10/- each

Rs. 0.400 million

60000

Preference Shares

Rs. 10/- each

Rs. 0.600 million

 

Total

 

Rs. 1.000 million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

10000

Equity Shares

Rs. 10/- each

Rs. 0.100 million

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2007

31.03.2006

31.03.2005

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

0.100

0.100

0.100

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

0.000

0.000

0.000

4] (Accumulated Losses)

(0.121)

(0.489)

(0.531)

NETWORTH

(0.021)

(0.389)

(0.431)

LOAN FUNDS

 

 

 

1] Secured Loans

0.307

0.493

0.952

2] Unsecured Loans

2.752

1.254

1.400

TOTAL BORROWING

3.059

1.747

2.352

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

3.038

1.358

1.921

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

0.619

0.337

0.196

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.004

0.004

0.004

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

1.268

0.691

0.849

 

Sundry Debtors

1.474

1.003

1.602

 

Cash & Bank Balances

0.717

0.091

0.045

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

0.762

0.312

0.204

Total Current Assets

4.221

2.097

2.700

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

1.838

1.116

1.019

 

Provisions

0.000

0.00

0.000

Total Current Liabilities

1.838

1.116

1.019

Net Current Assets

2.383

0.981

1.681

 

 

 

 

MISCELLANEOUS EXPENSES

0.032

0.036

0.040

 

 

 

 

TOTAL

3.038

1.358

1.921

 

 

 

 

 

 

 

 

 

 

 

 

 

PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

 

31.03.2007

31.03.2006

Sales Turnover

 

NA

NA

Total Income

 

NA

NA

 

 

 

 

Profit/(Loss) Before Tax

 

0.383

0.041

Provision for Taxation

 

0.000

0.000

Profit/(Loss) After Tax

 

0.383

0.041

 

 

 

 

Total Expenditure

 

NA

NA

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2007

31.03.2006

31.03.2005

Debt Equity Ratio

(Total Liability/Networth)

 

(87.52)

(2.87)

(2.36)

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.30

1.88

2.65

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Form 8

 

Name of the company

M/s NEISS LABS PRIVATE LIMITED

Presented By

Mr. Mohit Jain (Director)

1) Date and description of instrument creating the change

CC Hypothecation of Stocks Agreement dated 02.09.2002.

2) Amount secured by the charge/amount owing on the securities of charge

Rs.0.500 million

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

Hypothecation of Stocks of Medicines

4) Gist of the terms and conditions and extent and operation of the charge.

Margin money 25% and other terms and conditions as per bank norms.

5) Name and Address and description of the person entitled to the charge.

Punjab National Bank

Varanasi


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

 

 

 

 

 

 

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 41.96

UK Pound

1

Rs. 83.78

Euro

1

Rs. 65.82

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

-

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

26

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions